Neon Therapeutics (NTGN)

[ALERTS100%to10000%GAIN]

ack to News Results
Neon Therapeutics Shares Rise on Publication in Scientific Journal
6:44 pm ET September 5, 2019 (Dow Jones) Print


By Dave Sebastian

Shares of Neon Therapeutics Inc. (NTGN) rose more than 14% in after-hours trading Thursday after the company published a paper in a scientific journal that details a process for predicting MHC class II cancer-specific neoantigens.
The paper, titled "Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction," was published in the scientific journal Immunity.
The company said predicting cancer-specific antigens is a precursor to developing immunotherapies that could destroy malignant cells.
Neon said it will integrate the MHC class II prediction tool into its RECON bioinformatics platform, which identifies and predicts neoantigen targets associated with a patient's tumor.

Write to Dave Sebastian at [e-mail]